| Identification | Back Directory | [Name]
prednisolone farnesylate | [CAS]
118244-44-3 | [Synonyms]
PNF21
prednisolone farnesylate
Pregna-1,4-diene-3,20-dione, 11,17-dihydroxy-21-[[(2E,6E)-3,7,11-trimethyl-1-oxo-2,6,10-dodecatrien-1-yl]oxy]-, (11β)- | [Molecular Formula]
C36H50O6 | [MDL Number]
MFCD00887055 | [MOL File]
118244-44-3.mol | [Molecular Weight]
578.78 |
| Chemical Properties | Back Directory | [Boiling point ]
712.5±60.0 °C(Predicted) | [density ]
1.15±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [pka]
12.31±0.70(Predicted) |
| Hazard Information | Back Directory | [Uses]
Prednisolone farnesylate (PNF21) is a new transdermal corticosteroid with anti-inflammatory activity. | [Definition]
ChEBI: Prednisolone farnesylate is an organic molecular entity. | [References]
[1] Kato N, et al. Treatment of the chronic inflammation in peripheral target tissue improves the crushed nerve recovery in the rat: histopathological assessment of the nerve recovery. J Neurol Sci. 2002 Oct 15;202(1-2):69-74. DOI:10.1016/s0022-510x(02)00209-5 |
|
|